Liu Yansheng’s research group of Yale University School of Medicine mainly studies the identification of precise proteomics and large-scale quantitative techniques. It takes cell models and mouse models of chromosome variation in cancer and genetic diseases as research objects to study the dose effect, timing regulation, organelle localization and protein-protein interaction of proteins in cancer.
Introduction of Tutors and Laboratories
Dr. Liu Yansheng He did postdoctoral research at the Federal Institute of Technology in Zurich, Switzerland, and joined the Institute of Cancer Biology of Yale University as an assistant professor at the end of 2017.
Dr. Liu Yansheng, academic leader of the laboratory, specializes in quantitative proteomics DIA technology (Liu y. et al, cell2016, Liu y. et al, nature biotechnol, 2019) and applies it to phosphorylated proteome (rosenberger r r. *, Liu y. * et al. Nature Biotechnology 2017), plasma proteome (liu y.et al, molecular systems biology 2015) and down syndrome (liu y.et al, nature communications 2017), etc. In recent years, the first author or correspondent has published more than 30 articles in the magazines Cell, Nature Biotechnol, Nature Comm, PNAS, Molsystbio, Cell Rep, Molcell Proteomics, etc., with a total citation of more than 1600 times. He also served as editorial board of Proteomics, editorial board of Proteomics-Clinical Applications, and deputy editor-in-chief of Frontiers in Physiology.